Related Experiment Video
Updated: Aug 17, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon-alpha 2b inhibits proliferation of human Tenon's capsule fibroblasts
1Department of Ophthalmology, Prince of Wales Hospital, Randwick, NSW, Australia.
Insights
Interferon-alpha 2b (IFN-alpha) effectively inhibits fibroblast proliferation in vitro, showing promise as an antifibrotic treatment for ocular fibrosis after glaucoma surgery. Further research is warranted to explore its therapeutic potential.
Area of Science:
- Ophthalmology
- Fibrosis Research
- Immunology
Background:
- Glaucoma filtering surgery can lead to ocular fibrosis, a major cause of surgical failure.
- Fibroblast proliferation is a key process in the development of ocular fibrosis.
Purpose of the Study:
- To investigate the antifibrotic potential of interferon-alpha 2b (IFN-alpha).
- To evaluate IFN-alpha's ability to inhibit mitogen-induced proliferation of human Tenon's capsule fibroblasts in vitro.
Main Methods:
- Human Tenon's capsule fibroblasts were cultured in vitro.
- Cell proliferation was assessed using [3H]-thymidine incorporation.
- Fibroblast proliferation was induced by fetal calf serum and measured with and without IFN-alpha treatment.
Main Results:
- IFN-alpha demonstrated dose-dependent inhibition of fibroblast proliferation from 10 to 10,000 IU/ml (P < 0.001).
- Inhibition was observed even when IFN-alpha was added before the mitogen, with effects lasting at least 3 days (P = 0.001).
Conclusions:
- Interferon-alpha 2b exhibits significant in vitro antifibrotic properties.
- IFN-alpha warrants further investigation as a potential therapeutic agent to control ocular fibrosis post-glaucoma surgery.
Abstract:
To evaluate the potential of interferon-alpha 2b (IFN-alpha) as an antifibrotic treatment after glaucoma filtering surgery, we studied its ability to inhibit mitogen-induced proliferation of human Tenon's capsule fibroblasts in vitro, as shown by [3H]-thymidine incorporation. IFN-alpha inhibited fetal calf serum-induced proliferation in a dose-dependent manner in concentrations ranging from 10 to 10,000 IU/ml (P < 0.001). Inhibition was also found when IFN-alpha was added prior to the mitogen (P = 0.001); this inhibitory effect lasted at least 3 days. We suggest that IFN-alpha deserves further evaluation as a possible agent for the control of ocular fibrosis.
More Related Videos
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
09:11Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection
Published on: July 16, 2019
Related Concept Videos
Introduction to Fibroblasts
TGF - β Signaling Pathway
Inhibitors of Viral Protein Synthesis